GlassScriptPhysician profile
Anais Rameau
NPI 1144510439
$10,619.04
in general payments reported to CMS, 2019-2025
9 companies · $10K in 2025
The $10K reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2022: $107 · 2023: $247 · 2024: $82.72 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,559 · Consulting Fee: $4,000 · Food and Beverage: $738 · Education: $47.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,559.17 |
| Consulting Fee | $4,000.00 |
| Food and Beverage | $737.95 |
| Education | $47.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu A/S | $5,559.17 | 2025 | |
| Pentax of America, INC. | $4,359.36 | 2023-2025 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Regeneron Pharmaceuticals, INC. | $297.87 | 2023-2025 | |
| Covidien LP | $150.14 | 2019 | |
| Acclarent, INC | $84.97 | 2022 | |
| Merck Sharp & Dohme LLC | $80.72 | 2023 | |
| Precigen, INC. | $47.22 | 2025 | |
| Boston Scientific Corporation | $21.82 | 2022 | |
| Janssen Scientific Affairs, LLC | $17.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anais Rameau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.